%20(1).svg)
Drug Development & Delivery SPECIAL FEATURE: Outsourcing Formulation Development & Manufacturing
Drug Development & Delivery Magazine Contributor Cindy H. Dubin interviews Serán and several other leading companies on the critical relationship between CDMOs as innovators and solution providers in pharma and biotech.
Early & In-Depth Understanding of API Properties (Page 48)
Innovators are under increased pressure to reduce development timelines and deliver more challenging molecules. This molecular complexity includes increasing molecular weight, multiple active binding ligands (such as protein degradation and molecular glues), and limited bioavailability due to decreasing solubility and permeability. This new reality requires an early in-depth understanding of API properties and formulation risks in order to develop a robust, scalable formulation.
Serán’s VP, Business Operations, Rod Ketner, PhD, discusses Serán's science-based formulation screening to derisk technology selection and drug product formulations.
About Serán
Serán BioScience, LLC, is a science-driven Drug Development Partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.
For more information, visit www.Seranbio.com or email us at [email protected].
Contact
Serán BioScience, LLC
63047 Layton Ave, Bend, OR 97701 USA
www.seranbio.com
.svg)